GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mizuho Medy Co Ltd (TSE:4595) » Definitions » Institutional Ownership

Mizuho Medy Co (TSE:4595) Institutional Ownership : 4.71% (As of Jun. 09, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Mizuho Medy Co Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Mizuho Medy Co's institutional ownership is 4.71%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Mizuho Medy Co's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Mizuho Medy Co's Float Percentage Of Total Shares Outstanding is 0.00%.


Mizuho Medy Co Institutional Ownership Historical Data

The historical data trend for Mizuho Medy Co's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mizuho Medy Co Institutional Ownership Chart

Mizuho Medy Co Historical Data

The historical data trend for Mizuho Medy Co can be seen below:

2023-08-31 2023-09-30 2023-10-31 2023-11-30 2023-12-31 2024-01-31 2024-02-29 2024-03-31 2024-04-30 2024-05-31
Institutional Ownership 2.23 1.88 1.91 2.27 4.81 4.85 4.76 4.67 4.67 4.71

Mizuho Medy Co Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Mizuho Medy Co (TSE:4595) Business Description

Traded in Other Exchanges
N/A
Address
4 Fujinoki-Machi, Saga Prefecture, Tosu, JPN, 841-0048
Mizuho Medy Co Ltd engages in research and development, manufacture and distribution of in-vitro diagnostic products. The company provides immuno assay test products, such as influenza virus kits; Infectious diseases test kits; fecal occult blood test kits for detection of human hemoglobin and human transferrin in feces; and biochemical liquid stable reagents for professionals. It also offers HCG (midstream test), including digital p-check test for OTC. It also offers fruit tree virus test drugs to agricultural testing places.

Mizuho Medy Co (TSE:4595) Headlines

No Headlines